Atherosclerosis
Atherosclerosis
Atherosclerosis
ATHEROSCLEROSIS
athero-, ather- +
(Greek: groats, meal, porridge; soft, pasty materials)
sclero-, scler-
(Greek: hard, hardening)
Peripheral
Artery Disease
Aneurysm
http://www.who.int/nmh/publications/ncd_report_chapter1.pdf?ua=1
WHO IS AT RISK?
High cholesterol
What are the risk factors? Diabetes
Obesity
High CRP
Smoking
Stress test
Echocardiogram
Angiography
Lipid profile
Triglyceride
Cholesterol
HDL
LDL
Contrast is needed
Sit in scanner (15-20 mins)
Cannot detect small size (<2cm in size)
Angiography
Thin flexible tube is passed through
an artery, at the top of the leg or in
the arm to reach the arteries.
Look inside your artery to see if there
is any blockage.
A dye can be injected into the arteries
and monitor by x-ray to observe blood
flow.
Carried out during cardiac
catheterization (coronary
angiography).
Limitations:
Invasive
Provides dimensions of lumen only
Radiation exposure
Magnetic resonance imaging (MRI)
Uses a magnetic field from super
cooled magnets (NOT X-RAYS).
The strength of the magnetic field
cause the atoms of the body to
response, and the emissions are
detected by the scanner >
Analyzed> Image produced.
Shows detailed images of the
structure and beating of the
heart.
Image are detailed and very clear
(better than a CT scan).
Can distinguish between disease
and healthy tissues. Difficult to
differentiate inflamed and scar
tissues.
Not suitable for people who have
metal implants.
HOW DOES ATHEROSCLEROTIC LESION DEVELOP?
2004
Historical Breakthrough (3) ?
Clinical evidence?
Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable clinical goal.
Williams, Kevin; Feig, Jonathan; Fisher, Edward. Current Opinion in Lipidology. 18(4):443-450, August 2007.
Regression of Atherosclerosis
(Reverse Cholesterol transport in macrophage)
HDL metabolism and macrophage RCT. The liver and intestine synthesize and secrete apoA-I and
are primarily responsible for the lipidation of newly secreted lipid-poor apoA-I via ABCA1-mediated
cholesterol efflux.
Cholestyramine (Prevalite)
Colesevelam (Welchol)
Colestipol (Colestid)
Hypercholesterolemia
3. Cholesterol absorption inhibitors
× ×
×
Br J Cardiol 2012;19:126–33
currently under Phase III trial
Obicetrapib
completed Phase II trial
Modulate inflammation
Aspirin
>>anti-inflammation??
>> anti-platelet or anticoagulant
How about NSAID?
Graham, D.J. et al. Risk of acute myocardial infarction and sudden cardiac
death in patients treated with cyclo-oxygenase 2 selective and non-selective
non-steroidal anti-inflammatory drugs: nested case-control study. Lancet
365, 475-481, 2005.
“…Rofecoxib use increases the risk of serious coronary heart disease compared with celecoxib use. Naproxen use
does not protect against serious coronary heart disease…”
Biomolecule as Drug
What are the concerns?
WHAT CAN WE DO WHEN LESION IS FORMED?
Surgeries
Coronary angioplasty (“Balloon”)
Stent placement
Coronary artery bypass surgery (CABG)
Carotid artery surgery
Plaque removal
Coronary angioplasty
Open blocked or narrowed coronary arteries.
Relatively non-invasive
Therapeutic point of view
Where to go?
Percentage of People with Diabetes Aged 35 Years
or Older Reporting Heart Disease or Stroke, by
Age, United States, 1997–2011